Insider trading · Q3 2026 · CIK 1339005

Femasys Inc (FEMY) insider trading.

In Q3 2026, insiders at Femasys Inc reported 5 non-derivative transactions on 11 Forms 3, 4 and 5: 5 open-market purchases worth $134K and 0 sales.

Transactions
5
Purchases (P)
5
Sales (S)
0
Net shares, P minus S
41,875
Insiders
5
Last filed
2026-08-11

Insiders

InsiderRelationshipTransactionsBuysSales
Lee-Sepsick KathyDirector, Officer · Chief Executive Officer110
Elefant DovOfficer · Chief Financial Officer110
Canning John CharlesOfficer · Chief Operating Officer110
Sipos Jeremy AlexanderOfficer · Chief Technology Officer110
Mifek Jeffrey GeraldOfficer · Chief Clinical-Medical Affairs110

Transactions

5 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-08-07Lee-Sepsick KathyP (A)15,625$3.215,625Form 4
2026-08-07Elefant DovP (A)15,625$3.215,625Form 4
2026-08-07Canning John CharlesP (A)4,375$3.24,375Form 4
2026-08-07Sipos Jeremy AlexanderP (A)3,125$3.23,125Form 4
2026-08-07Mifek Jeffrey GeraldP (A)3,125$3.23,125Form 4

Transaction codes in this quarter

Get FEMY insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1339005&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · FEMY company page · Femasys Inc on SEC.gov

Questions

Are insiders buying or selling Femasys Inc (FEMY)?

In Q3 2026, insiders at Femasys Inc reported 5 non-derivative transactions on 11 Forms 3, 4 and 5: 5 open-market purchases worth $134K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Femasys Inc insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/femy.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.